169 related articles for article (PubMed ID: 2870944)
21. Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia.
Johnson DA; Ludlow JM; Street K; Taylor RD
Br J Psychiatry; 1987 Nov; 151():634-8. PubMed ID: 3446307
[TBL] [Abstract][Full Text] [Related]
22. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Dencker SJ; Frankenberg K; Hansen V; Malm U
Acta Psychiatr Scand Suppl; 1980; 279():29-40. PubMed ID: 6931471
[TBL] [Abstract][Full Text] [Related]
23. Simplified symptom registration in psychiatric trials: a statistical approach.
Hansen V; Hagen AS; Lehmann EH; Astrup C
Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
[No Abstract] [Full Text] [Related]
24. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
Kelly HB; Freeman HL; Banning B; Schiff AA
Int Pharmacopsychiatry; 1977; 12(1):54-64. PubMed ID: 406212
[TBL] [Abstract][Full Text] [Related]
25. Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia.
Bechelli LP; Navas-Filho F
Encephale; 1986; 12(3):121-5. PubMed ID: 2876879
[TBL] [Abstract][Full Text] [Related]
26. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
Wistedt B; Palmstierna T
J Clin Psychiatry; 1983 Oct; 44(10):369-71. PubMed ID: 6643398
[TBL] [Abstract][Full Text] [Related]
27. The decanoates of flupenthixol and clopenthixol in the treatment of chronic schizophrenic in-patients. Implications for community psychiatry.
Martyns-Yellowe IS
West Afr J Med; 1993; 12(2):110-3. PubMed ID: 8104468
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy of flupenthixol decanoate in schizoaffective disorder: a clinical evaluation.
Singh AN
J Int Med Res; 1984; 12(1):17-22. PubMed ID: 6692965
[TBL] [Abstract][Full Text] [Related]
29. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
Jain RC; Ananth JV; Lehmann HE; Ban TA
Curr Ther Res Clin Exp; 1975 Oct; 18(4):585-9. PubMed ID: 241609
[No Abstract] [Full Text] [Related]
30. A controlled comparison of flupenthixol decanoate injections and oral amitriptyline in depressed out-patients.
Tam W; Young JP; John G; Lader MH
Br J Psychiatry; 1982 Mar; 140():287-91. PubMed ID: 7093597
[TBL] [Abstract][Full Text] [Related]
31. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
Wistedt B
Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
[TBL] [Abstract][Full Text] [Related]
32. [Flupenthixol versus haloperidol in acute psychotic episodes].
Parent M; Toussaint C
Acta Psychiatr Belg; 1982; 82(6):617-31. PubMed ID: 7183131
[TBL] [Abstract][Full Text] [Related]
33. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
Dom R; De Mesmaecker L; van den Broucke M; van Hest T; Baro F
Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
[TBL] [Abstract][Full Text] [Related]
34. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
Chowdhury ME; Chacon C
Compr Psychiatry; 1980; 21(2):135-9. PubMed ID: 6991205
[No Abstract] [Full Text] [Related]
35. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
Coufal J; Novotný M
Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
[No Abstract] [Full Text] [Related]
36. A report on the use of flupenthixol in the maintenance treatment of psychotic patients at Ibadan, Nigeria.
Jegede RO; Ibazebo H
Afr J Psychiatry; 1981; 7(1-2):21-4. PubMed ID: 6122369
[No Abstract] [Full Text] [Related]
37. [Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
Pach J; Finkbeiner T; Glaser T; Haug J; Osterheider M; Tegeler J
Fortschr Neurol Psychiatr; 1998 Oct; 66(10):442-9. PubMed ID: 9825249
[TBL] [Abstract][Full Text] [Related]
38. Flupenthixol versus haloperidol in acute psychosis.
Parent M; Toussaint C
Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
[TBL] [Abstract][Full Text] [Related]
39. Neurotic depression accompanied by somatic symptoms: a double-blind comparison of flupenthixol and diazepam in general practice.
Grillage M
Pharmatherapeutica; 1986; 4(9):561-70. PubMed ID: 3763651
[TBL] [Abstract][Full Text] [Related]
40. Pipotiazine palmitate: a new depot neuroleptic.
Simpson GM; Varga V
Curr Ther Res Clin Exp; 1975 Mar; 17(3):276-80. PubMed ID: 236151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
